Anteo Diagnostics Limited
(ASX:ADO) CEO Dr Geoffrey Cumming presents at the ASX Investor Series in Sydney.
The life sciences company is focussed on in vitro diagnostics, point of care and life science research. Dr Cumming discusses the company’s pioneering molecular glue called Mix&Go and opportunities to extend its reach.
